BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Electric Last Mile, TAL Education, New Oriental, and Biogen and Encourages Investors to Contact the Firm
18 févr. 2022 21h00 HE | Bragar Eagel & Squire
NEW YORK, Feb. 18, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Biogen, Telos, Fennec, and Astra Space and Encourages Investors to Contact the Firm
13 févr. 2022 21h00 HE | Bragar Eagel & Squire
NEW YORK, Feb. 13, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
Life Clips Subsidiary Cognitive Apps To Benefit From Apple's iPhone Features to Help Detect Depression, Cognitive Decline
05 oct. 2021 07h30 HE | Life Clips Inc.
AVENTURA, Fla., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Life Clips, Inc. (OTC Pink: LCLP) (the “Company”), believes that Apple’s recently announced partnerships with Biogen and the University of...
Biogen_Logo_Standard-rgb_R.jpg
Biogen Announces Topline Results From Phase 2/3 Gene Therapy Study for XLRP
14 mai 2021 07h30 HE | Biogen Inc.
While the Phase 2/3 XIRIUS study did not meet its primary endpoint, data indicated positive trends in several prespecified secondary endpoints, such as a clinically relevant measure of visual...
logo-alt.png
Global Oral Solid Dosage Excipients Market estimated to be US$ 5.9 billion by 2030 with a CAGR of 7.9% during the forecast period - by PMI
02 mars 2021 10h05 HE | PMI
Covina CA, March 02, 2021 (GLOBE NEWSWIRE) -- Global Oral Solid Dosage Excipients Market accounted for US$ 2.8 billion in 2020 and is estimated to be US$ 5.9 billion by 2030 and is anticipated to...
BES_Mark.jpg
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Biogen, Inc. and Encourages Investors to Contact the Firm
08 janv. 2021 21h00 HE | Bragar Eagel & Squire
NEW YORK, Jan. 08, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that a class action lawsuit has been filed in the...
ViGeneron_Logo_NEW.png
ViGeneron signs global collaboration agreement for ophthalmic gene therapy development
05 janv. 2021 02h00 HE | ViGeneron GmbH
Collaboration with Biogen to develop gene therapy for an undisclosed target to treat inherited eye disease, plus option for additional targetThe companies will use ViGeneron’s proprietary vgAAV...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Interface, Cabot Oil & Gas, Biogen, and Stride and Encourages Investors to Contact the Firm
29 déc. 2020 17h00 HE | Bragar Eagel & Squire
NEW YORK, Dec. 29, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Biogen, Stride, JOYY, and Berry Corporation and Encourages Investors to Contact the Firm
22 déc. 2020 18h00 HE | Bragar Eagel & Squire
NEW YORK, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
LOGO.jpg
ROSEN, A TOP RANKED LAW FIRM, Reminds Biogen Inc. Investors of Important January 12 Deadline in First Filed Securities Class Action Commenced by the Firm; Encourages Investors with Losses in Excess of $1 Million to Contact the Firm – BIIB
22 déc. 2020 13h50 HE | The Rosen Law Firm PA
NEW YORK, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Biogen Inc. (NASDAQ: BIIB), between October 22, 2019 and...